Ms. Kruttika Purohit is a research student associated with the Australian Research Council Training Centre for Facilitated Advancement of Australia’s Bioactives (FAAB) at Macquarie University. Her current research involves investigating the ginger rhizome for novel bioactive peptides and their characterization using in silico studies and various in vitro bioactivity assays.
Dr. Narsimha Reddy has a strong background in the theory and
practice of nuclear magnetic resonance (NMR) spectroscopy and imaging. His
depth of knowledge in the analysis of multidimensional NMR experiments has led
him to design new NMR techniques. His recent research interests are in the
areas of bioactive proteins, peptides, and polysaccharides isolated from food
and herbal sources. Studies involving the biomolecular structure and function are
part of his current research. The development of nutraceuticals, functional foods,
and other natural compounds of therapeutic value are some of his medium- to
long-term goals. He has published several papers in refereed scientific
journals. He is also a life member of the National Magnetic Resonance Society,
India, and a member of the Australian (1993–2024) and New Zealand Society for
Magnetic Resonance (2007–2017).
Professor Anwar Sunna currently serves as Director of the
Biomolecular Discovery Research Centre (BDRC) at Macquarie University, Director
of the Master of Biotechnology, and one of the Directors of Synthetic Biology
Australasia. Additionally, he is also the Partnerships Director of the
Australian Research Council Training Centre for Facilitated Advancement of
Australia’s Bioactives (FAAB). His research focuses on conducting original,
multidisciplinary applied research, which is mostly industrially oriented.
Professor Sunna is an expert in the field of biotechnology and synthetic
biology, with a focus on developing new tools and techniques for bioprocessing
and biomanufacturing. He has made significant contributions to the development
of novel methods for the bio-functionalization of inorganic materials for
diagnostics and therapeutics by incorporating new synthetic solid-binding
peptides. His research has also focused on the use of novel synthetic cell-free
multi-enzyme pathways for industrial applications, such as the conversion of
spent coffee grounds and organic wastes into bio-based chemicals.